Cargando…
The 150 most important questions in cancer research and clinical oncology series: questions 94–101: Edited by Cancer Communications
Since the beginning of 2017, Cancer Communications (former title: Chinese Journal of Cancer) has published a series of important questions regarding cancer research and clinical oncology, to provide an enhanced stimulus for cancer research, and to accelerate collaborations between institutions and i...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6257962/ https://www.ncbi.nlm.nih.gov/pubmed/30477575 http://dx.doi.org/10.1186/s40880-018-0341-9 |
Ejemplares similares
-
The 150 most important questions in cancer research and clinical oncology series: questions 67–75: Edited by Chinese Journal of Cancer
Publicado: (2017) -
The 150 most important questions in cancer research and clinical oncology series: questions 76–85: Edited by Chinese Journal of Cancer
Publicado: (2017) -
The 150 most important questions in cancer research and clinical oncology series: questions 57–66: Edited by Chinese Journal of Cancer
Publicado: (2017) -
The 150 most important questions in cancer research and clinical oncology series: questions 86–93: Edited by Chinese Journal of Cancer
Publicado: (2018) -
The 150 most important questions in cancer research and clinical oncology series: questions 6–14: Edited by Chinese Journal of Cancer
Publicado: (2017)